Recurrent ischaemia during continuous multilead ST-segment monitoring identifies patients with acute coronary syndromes at high risk of adverse cardiac events: Meta-analysis of three studies involving 995 patients

European Heart Journal

Volumn 22, Issue 21, 2001, Pages 1997-2006

  Akkerhuis, K Martijn ^a   Klootwijk, P A J ^a   Lindeboom, W ^b   Umans, V A W M ^c   Meij, S ^a   Kint, P P ^b   Simoons, M L ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b CARDIALYSIS   (Netherlands)

^c Northwest Clinics   (Netherlands)

Author keywords

Acute coronary syndromes; ECG monitoring; Electrocardiography; Ischaemia; Prognosis; Unstable angina

Indexed keywords

FIBRINOGEN RECEPTOR ANTAGONIST;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ELECTROCARDIOGRAM; FEMALE; HEART DEATH; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; ST SEGMENT;

ACUTE DISEASE; ANGINA, UNSTABLE; CAUSE OF DEATH; CORONARY DISEASE; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; MYOCARDIAL ISCHEMIA; PROGNOSIS; RECURRENCE;

EID: 0035186385     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.2001.2750     Document Type: Article

References (30)

1. Silent ischemia as a marker for early unfavorable outcomes in patients with unstable angina
2. Prognostic significance of silent myocardial ischemia in patients with unstable angina
3. Prognostic implications of transient-predominantly silent-ischemia in patients with unstable angina pectoris
4. Long-term prognosis in unstable angina. The importance of early risk stratification using continuous ST segment monitoring
5. Reduction of recurrent ischemia with abciximab during continuous ECG-ischemia monitoring in patients with unstable angina refractory to standard treatment (CAPTURE)
6. Relative contributions of a single-admission 12-lead electrocardiogram and early 24-hour continuous electrocardiographic monitoring for early risk stratification in patients with unstable coronary artery disease
7. Admission risk assessment by cardiac troponin-T in unstable coronary artery disease: Additional prognostic information from continuous ST-segment monitoring
8. ST-segment monitoring with continuous 12-lead ECG improves early risk stratification in patients with chest pain and ECG nondiagnostic of acute myocardial infarction
9. Recurrent ischemia during continuous 12-lead ECG-ischemia monitoring in patients with acute coronary syndromes treated with eptifibatide: Relation with death and myocardial infarction
10. Comparison of usefulness of computer-assisted continuous 48-h 3-lead with 12-lead ECG-ischaemia monitoring for detection and quantitation of ischaemia in patients with unstable angina
11. Dynamic on-line vectorcardiography improves and simplifies in-hospital ischemia monitoring of patients with unstable angina
12. Safety and preliminary efficacy of one-month glycoprotein IIb/IIIa inhibition with lefradafiban in patients with acute coronary syndromes without persistent ST-elevation
13. Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: The CAPTURE study
14. Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes
15. Accurate, clinically practical system for spatial vectorcardiography
16. On deriving the electrocardiogram from vectorcardiographic leads
17. Predictors of outcome in patients with acute coronary syndromes without persistent ST-elevation: Results from an international trial of 9,461 patients
18. Clinical and therapeutic profile of patients presenting with acute coronary syndromes who do not have significant coronary artery disease
19. Prognostic value of the admission electrocardiogram in acute coronary syndromes
20. Independent prognostic value of serum creatine kinase isoenzyme-MB mass, cardiac troponin-T and myosin light-chain levels in suspected acute myocardial infarction
21. Relation between troponin-T and the risk of subsequent cardiac events in unstable coronary artery disease
22. Acute coronary syndromes: Diagnosis
23. Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin-T levels
24. Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban
25. Platelet glycoprotein IIb/IIIa receptor inhibition in non-ST-elevation acute coronary syndromes: Early benefit during medical treatment only, with additional protection during percutaneous coronary intervention
26. Optimal timing of percutaneous intervention (PCI) in unstable angina
27. Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC-II prospective randomised multicentre study
28. Risk stratification in patients with unstable angina. 'Deja vue all over again?'
29. Continuous multi-lead ST-monitoring identifies patients with unstable coronary artery disease who benefit from long-term antithrombotic treatment. FRISC-II substudy
30. Does continuous vectorcardiography and continuous 12-lead ECG in patients identify the same patients in unstable coronary artery disease